scholarly journals Giant cell tumor formation due to metallosis after open latarjet and partial shoulder resurfacing

2020 ◽  
Vol 12 (2) ◽  
Author(s):  
Matthew Wolfson ◽  
Patrick Curtin ◽  
Emily J. Curry ◽  
Sandra Cerda ◽  
Xinning Li

Shoulder metallosis with giant cell tumor formation is rarely seen in shoulder surgery. With an increase in shoulder arthroplasty and complex revision shoulder surgeries, clinicians should have an index of suspicion for possible metallosis in patients that presents with unexplained persistent pain with metal components on both the glenoid and humeral side. This case describes a 43-yearold female with a history of six prior shoulder surgeries who presented with shoulder metallosis and giant cell tumor formation after a screw from her open Latarjet procedure began rubbing against her Hemicap implant. She successfully underwent a revision total shoulder arthroplasty for post traumatic arthritis with pectoralis major transfer for her chronic subscapularis rupture and had complete symptom resolution.

2017 ◽  
Vol 2017 ◽  
pp. 1-4
Author(s):  
Ali Azadi ◽  
James A. Bradley ◽  
Dennis M. O’Connor ◽  
Amir Azadi ◽  
Donald R. Ostergard

Background. Polypropylene material is widely used in gynecological surgery. There are few reports regarding its carcinogenic potential. There is lack of evidence supporting tumor formation directly attributed to the use of polypropylene material. Case. This patient is a 49-year-old woman with a history of stress urinary incontinence which required a MiniArc® Sling who presented with a hard, tender, immobile mass on the anterior vaginal wall. Pathological analysis of the mass revealed a tumor-like reaction to the polypropylene material that resembled a giant cell tumor of soft tissue. Conclusion. The use of polypropylene in surgery is ubiquitous across disciplines; thus consideration for a tumor-like reaction to the material should exist for patients who present with a mass near the surgical site.


2015 ◽  
Vol 2015 ◽  
pp. 1-6 ◽  
Author(s):  
Cory Julian Broehm ◽  
Erika L. Garbrecht ◽  
Jeff Wood ◽  
Therese Bocklage

Giant cell tumor (GCT) of bone is a generally benign, but often locally aggressive, neoplasm of bone, with a propensity for recurrence. Sarcomatous transformation is rare and typically occurs with a history of recurrences and radiation treatment. Denosumab, an inhibitor of the RANK ligand involved in bone resorption in GCT, is increasingly used in treatment of recurrent or unresectable giant cell tumor of bone. We report two cases of sarcomatous transformation of GCT to osteosarcoma in patients receiving denosumab. One was a 59-year-old male with a 12-year history of GCT and multiple recurrences taking denosumab for 2.5 years. The second case was in a 56-year-old male with a seven-year history of GCT taking denosumab for six months. Review of the literature shows one case report of malignant transformation of GCT in a patient being treated with denosumab. As the use of denosumab for treatment of GCT will likely increase, larger, controlled studies are needed to ascertain whether denosumab may play a role in malignant transformation of giant cell tumor of bone.


2013 ◽  
Vol 2013 ◽  
pp. 1-5 ◽  
Author(s):  
Reiner Wirbel ◽  
Frank Blümler ◽  
Dirk Lommel ◽  
Guido Syré ◽  
Veit Krenn

A 27-year-old man treated 2.5 years ago for synchronous multicentric giant cell tumor of bone located at the right proximal humerus and the right 5th finger presented now with complaints of pain in his right hip and wrist of two-month duration. Radiology and magnetic resonance revealed multicentric giant cell tumor lesions of the right proximal femur, the left ileum, the right distal radius, and the left distal tibia. The patient has an eighteen-year history of a healed osteosarcoma of the right tibia that was treated with chemotherapy, resection, and allograft reconstruction. A literature review establishes this as the first reported case of a patient with synchronous and metachronous multicentric giant cell tumor who also has a history of osteosarcoma.


2019 ◽  
Vol 23 (1) ◽  
pp. 114-119
Author(s):  
A.V. Hryhorovska

Tenosynovial giant cell-tumor is a benign tumor of the synovial layer of the joints; for a long time to characterize this nosology, the term “villous- nodular synovitis” was used and considered it as a kind of inflammatory post-traumatic process in the joint capsule, and only in-depth studies of the properties of TSGCT at the molecular and cytogenetic levels proved its neoplastic nature. The purpose — to determine the peculiarities of approaches to differential diagnosis of TSGCT with exudative-proliferative syndromes, based on the clinical and morphological studies of biopsy-resection material. The study was performed on 95 cases of TSGCT of diffuse type of different localization, 56 cases of rheumatoid arthritis and 48 cases of non-specific post-traumatic pigmented synovitis. Grades of expressiveness of morphological indicators were evaluated according to the visual-analog scale from low to high with an increase of x100. Hypertrophic, hyperplastic and inflammatory changes in the articular capsule in cases of nonspecific pigmented synovitis are limited to a synovial layer. Hemosiderin is found in the cytoplasm of synovial cells and in siderophages. Nodular and solid proliferators, signs of invasion in adjacent tissues, are absent, which is an important feature in the differential diagnosis of lesions of the joint capsule, rich in clusters of macrophage siderocytes. At histological examination in isolated tissues in patients with rheumatoid arthritis signs of chronic non-specific productive-infiltrative and exudative inflammation of different activity were found — a cluster of mononuclears and plasmacites with the formation of small lymphoid follicles in its own synovial plate, hyperemia of the microcirculatory bed, and fibrin layers. The difference between the described synovitis from TSGCT is the absence of nodular proliferators, infiltrative changes in the deep departments of the capsule, hemorrhages, clumps of hemosiderin and large epithelioid synovitis, which is characteristic of tumors. TSGCT is characterized by polymorphism of histological changes and different degrees of prevalence in joint structures, which in many cases complicates its differential diagnosis.


Author(s):  
Geethu G. Nair ◽  
Rajan G. ◽  
Supriya N. K. ◽  
Sathi P. P.

Tumors that are metastasizing generally considered as malignant. But there are exceptions. Giant cell tumor of bone is well known for its potential to metastasize without sarcomatous transformation. Potential of benign GCT to metastasize was first reported by Jaffe et al in 1940. Prevalence of pulmonary metastasis in benign GCT is between 1-9%. Factors favoring metastasis include recurrence of tumor, surgical manipulation of initial bone tumor, location of femur etc. Peripheral or basilar portion of pulmonary parenchyma is involved commonly. Eventhough death reported in 16-25% of cases, overall it has a favorable prognosis. Surgical resection is preferred treatment for pulmonary metastasis. In the present study 2 case studies were done. In 1st study 18 year old female, known case of GCT Lt tibia, with history of curetting and cementing presented with pain and swelling at same site and pulmonary metastasis 1 year later. Biopsy from initial as well as recurrent tumor confirmed benign GCT without any features of atypia, mitosis or necrosis. Aspirate from pulmonary lesion showed osteoclastic giant cells. No treatment given to metastatic deposits and is asymptomatic even though size of pulmonary lesions is increasing. And in second study a 22 year old female, with past history of GCT referred to our institution for evaluation of lung lesion detected in X-ray. Patient underwent metastatectomy here and histopathology was similar to that of bone lesion. There was no evidence of sarcomatous transformation both in initial and recurrent lesion. Patient is asymptomatic other wise and doing well.


2008 ◽  
Vol 23 (1) ◽  
pp. 47-49 ◽  
Author(s):  
Susumu Kobayashi ◽  
Masaki Hara ◽  
Motoki Yano ◽  
Hisashi Tateyama ◽  
Yuta Shibamoto

1994 ◽  
Vol 80 (1) ◽  
pp. 148-151 ◽  
Author(s):  
Lee Reed ◽  
Crystl D. Willison ◽  
Sydney S. Schochet ◽  
Joseph L. Voelker

✓ A giant cell tumor involving the vertex of the skull is described in a 3-year-old child with no history of head trauma. The mass was present approximately 4 months prior to resection. Microscopically, the lesion consisted of highly cellular tissue composed of oval to spindle-shaped stromal cells admixed with numerous multinucleated giant cells. Giant cell tumor of the skull is a rare lesion, usually involving the sphenoid or temporal bone in adults. The differential diagnosis is discussed with reference to the literature regarding giant cell lesions, especially of the cranium. The authors are unaware of previous reports of a similar lesion in this location in such a young child.


2021 ◽  
pp. 014556132110029
Author(s):  
Shiori Suzuki ◽  
Hiroshige Tsuda ◽  
Nobuyuki Bandoh ◽  
Takashi Goto ◽  
Akihiro Uemura ◽  
...  

A 74-year-old Japanese woman with a 1-year history of right preauricular pain and a 2-month history of bleeding from the right ear was admitted to our department. Tumor was observed in the anterior wall in the right external auditory canal. Bony swelling of the right preauricular area was palpated. Computed tomography revealed an ill-defined, osteogenic tumor around the mandibular condyle with a destructive bony lesion involving the temporal bone. Magnetic resonance imaging revealed a 2.0 × 1.5 × 1.3-cm solid tumor around the mandibular condyle, exhibiting a low-intensity signal on T1-weighted imaging and an isointense central area surrounded by low-signal intensity on T2-weighted imaging. Histological examination of biopsy specimens revealed diffuse-type tenosynovial giant cell tumor (D-TGCT). After the feeding arteries for the tumor were embolized, the patient underwent surgery with combined temporal craniotomy and mandibular condylectomy. The soft and cystic tumor with calcification located in the extradural space was totally resected along with the mandibular condyle. No facial paralysis or recurrence was evident as of 6 months postoperatively. To date, only 23 cases of D-TGCT arising in the temporomandibular joint (TMJ) with ear involvement have been reported since 2011. We report successful resection of a rare case of D-TGCT arising in the TMJ.


Sign in / Sign up

Export Citation Format

Share Document